Difference between revisions of "Industrial fermentation"

Jump to navigation Jump to search
m
Line 174: Line 174:
AmphiStar has developed a proprietary technology platform for the cost-efficient and ecological production of biosurfactants. We are a founders-led spin-off company established in July 2021 that is the result of 15 years joint development between Ghent University (Inbio.be) and the Bio Base Europe Pilot Plant. We derisk the early development stage for biosurfactant production, guide and support technology transfer to industrial manufacturers and collaborate intensely for further development and improvement of the licensed technology. Our technology platform is initially based on the fermentative production with the yeast ''Starmerella bombicola'', producing many different biosurfactants at a high volumetric productivity. Our biosurfactants are made from sustainable, renewable feedstocks and waste streams. Microbial fermentation is a clean production technology that is safe for people and the environment. Our biosurfactants are environmentally friendly, palm oil-free, sulfate-free, mild, non-toxic and non-irritant.
AmphiStar has developed a proprietary technology platform for the cost-efficient and ecological production of biosurfactants. We are a founders-led spin-off company established in July 2021 that is the result of 15 years joint development between Ghent University (Inbio.be) and the Bio Base Europe Pilot Plant. We derisk the early development stage for biosurfactant production, guide and support technology transfer to industrial manufacturers and collaborate intensely for further development and improvement of the licensed technology. Our technology platform is initially based on the fermentative production with the yeast ''Starmerella bombicola'', producing many different biosurfactants at a high volumetric productivity. Our biosurfactants are made from sustainable, renewable feedstocks and waste streams. Microbial fermentation is a clean production technology that is safe for people and the environment. Our biosurfactants are environmentally friendly, palm oil-free, sulfate-free, mild, non-toxic and non-irritant.


=== Bluecon Biotech GmbH ===
=== Blucon Biotech GmbH ===
{{Infobox provider-industrial fermentation|Company=BlueCon Biotech GmbH|Country=Germany|Contact=Dr. Stefan Verseck; blucon@blucon-biotech.com|Webpage=https://blucon-biotech.com|Technology name=Industrial Fermentation|TRL=3-4|Product=2-hydroxypropionic acid (L- lactic acid)|Feedstock=cellulosic waste from paper recycling or pulp & paper production (non-food cellulosic); Dried Distillers Grains with Solubles (DDGS); Beet pulp; Agriculture residues (grasses (straw, corn stover, bagasse, miscanthus, switchgrass, sorghum), wood type materials (poplar, spruce, cotton stalks)|Microorganism=thermophilic bacteria|Image=Logo-blucon-normal.gif}}
{{Infobox provider-industrial fermentation|Company=BluCon Biotech GmbH|Country=Germany|Contact=Dr. Stefan Verseck; stefan.verseck@blucon-biotech.com|Webpage=https://blucon-biotech.com|Technology name=Industrial Fermentation|TRL=3-4|Product=Produkt L-lactic acid (polymer grade)|Feedstock=Variety of feedstock materials from agriculture, like grasses (straw, corn stover, bagasse, miscanthus, switchgrass, sorghum), wood type materials (poplar, spruce, cotton stalks) or from industrial processes ( cellulosic waste from paper recycling or pulp&paper production, Dried Distillers Grains with Solubles (DDGS), beet pulp)|Microorganism=thermophilic bacteria|Image=Blucon_Logo.jpg|Capacity=not relevant|Aeration=no (anaerobic process)|Biosafety lavel=Non-GMO|Agitator=not relevant|Controlled parameters=not relevant|Reactor material=not relevant|Other=not relevant}}
BluCon Biotech GmbH was founded in June 2017 and has its research laboratories and offices at the BioCampus, Cologne. The company continues to develop a unique technology by which L-lactic acid can be produced at lowest possible production costs so that the bioplastic poly lactic acid (PLA) will become commercially competitive to fossil fuel based plastics.


Such technology development has been initiated and carried out by Direvo Industrial Biotech GmbH in Cologne. Patents and know how have been acquired from Direvo by Zheijiang Youcheng group, Hangzhou, China. Chinese startup company, Dehong Biotech Ltd. has been entrusted to drive the commercialization of BluCon technology. Dehong in turn has entrusted BluCon Biotech GmbH to carry out strain and process development towards commercial process. BluCon Biotech GmbH is also partnering with Dehong, Hangzhou, to build and operate a biotechnology laboratory in Hangzhou and implement BluCon technology there.
BluCon Biotech GmbH was founded in June 2017 and has its research laboratories and offices at the BioCampus, Cologne. The company develop a unique technology by which L-lactic acid can be produced at lowest possible production costs so that the bioplastic poly lactic acid (PLA) will become commercially competitive to fossil fuel-based plastics.


BluCon Biotech GmbH collaborates with Shanghai Tong Jie Liang Biomaterials Ltd. (TJL) for the production of PLA and thus is very well integrated downstream. TJL is also building a research and development laboratory in Hangzhou, Zheijiang, China.
To reduce significantly the production costs low-cost raw materials are used, (e.g., cellulosic waste) and a sustainable process which most efficiently converts these feedstocks to the product, L-lactic acid (2nd generation L-lactic acid). Such technology development has been initiated and carried out by Direvo Industrial Biotech GmbH in Cologne. BluCon Biotech GmbH now drives the commercialization of this technology by modern strain and bioprocess engineering.
 
The unique technology of BluCon Biotech GmbH enables consolidated bioprocessing (CBP) of lignocellulosic feedstocks to L-lactic acid using thermophilic bacteria in a one step process. Our aim is to exclusively use cheap non-food cellulosic or lignocellulosic feedstock and to create a 2nd generation L-lactic acid process, thus to convert waste to value.  


Besides developing BluCon technology to commercial stage, BluCon Biotech GmbH serves as a platform to acquire further technologies in the field of applied biotechnology. With its core team, the company shows outstanding expertise in microbiology of extremophilic bacteria, in strain and process development and in project management. It is very well connected both in Germany and internationally.
Besides developing BluCon technology to commercial stage, BluCon Biotech GmbH serves as a platform to acquire further technologies in the field of applied biotechnology. With its core team, the company shows outstanding expertise in microbiology of extremophilic bacteria, in strain and process development and in project management. It is very well connected both in Germany and internationally.
Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Navigation menu